Effect of Tulsi (Ocimum Sanctum) on Biochemical Parameters in Young Overweight and Obese Subjects
NCT ID: NCT02681939
Last Updated: 2016-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
30 participants
INTERVENTIONAL
2016-02-29
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anti-obesity Effects of Dandelion (Taraxacum Officinale L.)
NCT06625736
Bioavailabity of the Major Metabolites of a Botanical Extract, in Healthy Adults
NCT05098093
Effect of Black Cumin Seed Oil Supplementation on Cortisol, Stress and Mood
NCT06950424
Safety and Efficacy Study of Herbal Supplements in Prediabetic and Mild to Moderate Hyperlipidemic Patients
NCT01680211
The Effect of Olive Leaf Extract Administration on Cardiovascular Health
NCT02990637
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tulsi
One capsule of Tulsi (Ocimum sanctum) orally, every morning and evening in empty stomach for 60 days regularly.
Tulsi(Ocimum sanctum Linn.) capsules
No Tulsi
No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tulsi(Ocimum sanctum Linn.) capsules
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Not on drugs like fluoroquinolones, anticonvulsants, antihypertensives, corticosteroids, hormonal contraceptives, hypolipidemic agents, anti psychotics, protease inhibitors and isotretinoin.
* Not suffering from liver disease, malabsorption, nephrotic syndrome, thyroid disorder, allergy or any other chronic disease.
17 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
All India Institute of Medical Sciences, Bhubaneswar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Sushil Chandra Mahapatra
Professor and Head, Department of Physiology, All India Institute of Medical Sciences, Bhubaneswar
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sushil Ch Mahapatra, MBBS, MD
Role: PRINCIPAL_INVESTIGATOR
All India Institute of Medical Sciences, Bhubaneswar
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
All India Institute of Medical Sciences, Bhubaneswar
Bhubaneswar, Odisha, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
T/IM-NF/Physio/15/04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.